Court termeMoyen termeLong termeSignaux

SELLAS Life Sciences [SLS]

Bourse : NASDAQ
Secteur : Healthcare
Industrie : Biotechnology
Dernière mise à jour 23 Jun 2026 @ 13:34 (Exchange is open)
Dernier : $9.12 6.93%
0.61 (↑)
GaG Algo Score™
v1.0
Court
0.61 (↑)
Moyen
2.50 (↑)
Long
1.94 (↑)
ACHAT
59.18%
rendement 32.32%
VENTE
64.00%
rendement -26.16%

Statistiques

Volume du jour 4.75M
Volume moyen 7.50M
Capitalisation 1.22B
BPA $-0.0487 (Q1 | 2026-05-12)
Prochaine date de résultats ($-0.0500) 2026-08-11
Dernier dividende $0.420 (2010-12-09)
PER -39.66 (Secteur) 26.21 (Industrie) 17.28
ATR14 $0.669 (8.31%)
Mouvement journalier possible $7.72 - $8.38 (8.67%)

Niveaux de support et résistance

Ligne

Données pivot

Statistiques pivot
Métrique Moyenne Médiane Écart type
Gain % 50.50% 30.17% 51.20%
Perte % -18.88% -18.88% 6.11%
Durée 16.0d 12d 11.5d
Total des pivots trouvés 6
Segments gain/perte 5 (3 Gain / 2 Perte)
Dernier pivot Top @ $8.05 le 2026-06-18
Variation depuis le dernier pivot $0.00 (0.00%)
Prévision du prochain pivot Dernier : $9.12
Prochain type prévu Bottom
Prix prévu (moy.) $6.53
Prix prévu (médiane) $6.53
Fourchette de prix prévue (~68%) $6.04 - $7.02
Variation vers cible moyenne $-2.59 (-28.41%)
Date prévue (moy.) 2026-07-04
Plage de dates prévue (~68%) 2026-06-22 - 2026-07-15
Base Based on 2 historical losses (Avg: -18.88%, Median: -18.88%, StdDev of Abs: 6.11%) and duration (Avg: 16.0 days, StdDev: 11.5 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

SELLAS Life Sciences climbs 3.74%.

SELLAS Life Sciences (SLS) stock price soared on Thursday after the stock rose $0.290 (3.74%) from the previous session on very high volume. The stock moderately outperformed the market today, rising faster than the NASDAQ's 1.91% gain. A total of 14.75M stocks were traded yesterday, valued at $118.72M, 10.07M shares more than the previous day (4 681 748 shares traded). This is above the average volume for the stock at 5.98M shares traded per day.

SELLAS Life Sciences signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

SELLAS Life Sciences Support & Resistance Levels

The stock is approaching the closest resistance level at $8.33. approximately $0.280 (3.48%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $8.97. On a fall back there will be support at $6.53 The dis das resistance s16.53 -

SELLAS Life Sciences Evaluation

  • Court score: 0.61
  • Moyen score: 2.50
  • Long score: 1.94